Michael Patrick Miller, EVP, US Commercial at Jazz Pharmaceuticals, holds 43.36K shares in Puma Biotechnology (Ticker: PBYI), holds 22.12K shares in Jazz Pharmaceuticals (Ticker: JAZZ), holds ― shares in Bioxcel Therapeutics (Ticker: BTAI). Most recently, Michael Patrick Miller Sold ― shares of Puma Biotechnology on Nov 09, 2023 for an estimated value of 70.75K.